Skip to main content

TD Asset Management Inc

Position in MLTX — MoonLake Immunotherapeutics

CIK 1056053 Toronto, A6

Position in MLTX

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$2,497,494
-$162,545 QoQ
Shares Held
128,274
-10.1% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 172 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,140,636,067 across 120 Biotechnology names. MLTX ranks #69 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MLTX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,497,494 128,274
2026-03-31 $2,660,039 142,706
2025-12-31 $1,670,485 126,744
2025-09-30 $764,393 106,610
2025-06-30 $8,786,374 186,152
2025-03-31 $8,474,439 216,904
2024-12-31 $14,167,481 261,634
2024-09-30 $10,882,350 215,834
2024-06-30 $9,200,018 209,234
2024-03-31 $10,251,641 204,094
2023-12-31 $12,630,085 209,142
2023-09-30 $11,422,230 200,390
2023-06-30 $5,081,640 99,640
2023-03-31 $1,439,803 67,312
2022-12-31 $706,776 67,312
2022-09-30 $522,341 67,312
2022-06-30 $152,071 28,966